annb0t
Top 20
ResMed Inc. RMD is gaining from the global supply of its cloud-connected platforms, AirSense10 and AirSense11. The strong uptake of the myAir app with Air 11 is likely to drive higher adherence to therapy in patients. However, escalating debt levels and competitive landscape are a concern.
In the past six months, this Zacks Rank #2 (Buy) stock has gained 36.7% compared with a 16.1% rise of the industry and a 23% increase of the S&P 500 composite.
The renowned medical device company has a marke...
>>> Read more: Here's Why Investors Should Buy ResMed (RMD) Stock Now
In the past six months, this Zacks Rank #2 (Buy) stock has gained 36.7% compared with a 16.1% rise of the industry and a 23% increase of the S&P 500 composite.
The renowned medical device company has a marke...
>>> Read more: Here's Why Investors Should Buy ResMed (RMD) Stock Now